SS

Santosh Sahebarav Pagire

Active Director Director DIN 08362840
DIN 08362840 First appointment Feb 2019 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Santosh Sahebarav Pagire

Data last updated:

Santosh Sahebarav Pagire is a Director at Setkariraja Pharma Private Limited (since 2019). The company operates in Business Services.

DIN 08362840
Primary Designation Director
Industry Business Services
First Appointment 14 Feb 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Setkariraja Pharma Private Limited U74999PN2019PTC182213
Director14 Feb 20192019Active

Board colleagues of Santosh Sahebarav Pagire

NameDINCompanyDesignation
Ajinkya Sambhaji Dahatonde08362841Setkariraja Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Setkariraja Pharma Private Limited
Premium access

Shareholding and investment profile for Santosh Sahebarav Pagire

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Sahebarav Pagire

Santosh Sahebarav Pagire currently holds 1 directorship: Setkariraja Pharma Private Limited (Director, since 14 Feb 2019).

Santosh Sahebarav Pagire was first appointed on 14 Feb 2019 as Director at Setkariraja Pharma Private Limited.

The current boards of Santosh Sahebarav Pagire's companies include Ajinkya Sambhaji Dahatonde (Setkariraja Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available